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Abstract: Chitosan is a versatile compound with multiple biotechnological applications. This polymer
inhibits clinically important human fungal pathogens under the same carbon and nitrogen status as
in blood. Chitosan permeabilises their high-fluidity plasma membrane and increases production of
intracellular oxygen species (ROS). Conversely, chitosan is compatible with mammalian cell lines as
well as with biocontrol fungi (BCF). BCF resistant to chitosan have low-fluidity membranes and high
glucan/chitin ratios in their cell walls. Recent studies illustrate molecular and physiological basis of
chitosan-root interactions. Chitosan induces auxin accumulation in Arabidopsis roots. This polymer
causes overexpression of tryptophan-dependent auxin biosynthesis pathway. It also blocks auxin
translocation in roots. Chitosan is a plant defense modulator. Endophytes and fungal pathogens
evade plant immunity converting chitin into chitosan. LysM effectors shield chitin and protect fungal
cell walls from plant chitinases. These enzymes together with fungal chitin deacetylases, chitosanases
and effectors play determinant roles during fungal colonization of plants. This review describes
chitosan mode of action (cell and gene targets) in fungi and plants. This knowledge will help to
develop chitosan for agrobiotechnological and medical applications.
Keywords: chitosan; antimicrobial compounds; auxin; effectors; LysM motifs; plant immunity; ROS
1. Introduction
Chitosan is a linear polymer of beta-(1-4)-linked N-acetyl-2-amino-2-deoxy-D-glucose (acetylated)
and 2-amino-2-deoxy-D-glucose (deacetylated [1]) subunits (Figure 1) [2]. Partial deacetylation of
chitin by enzymatic or chemical processes generates chitosan [3]. Chitin is a key component of the
cuticle of insects and exoskeleton of crustaceans, the cell wall of true fungi and that of some algae [1].
The main sources of chitosan production for commercial applications are marine crustaceans (mainly
shrimps). The main way to synthetize chitosan is by chemical methods. Acids demineralize crustacean
exoskeletons. Sodium hydroxide removes proteins from demineralized shells. Strong bases deacetylase
chitin and yield chitosan [4]. Enzymatic methods can also produce chitosan. Chitin deacetylases
(CDAs) generate chitosan from chitin. Combinations of chitin oligosaccharide deacetylases modify
the pattern of polymer deacetylation [5–7]. Some fungal plant pathogens generate chitosan [8] during
early infection to avoid host defenses [9]. CDA from the endophyte Pestalotiopsis sp. generates chitosan
oligomers that unlike its chitin substrates no longer elicit plant immunity [10]. The nematophagous
fungus Pochonia chlamydosporia produces chitosan during Meloidogyne javanica egg infection [11].
The fungus overexpresses CDA and chitosanase encoding genes in this process [11]. The activity of
the catalytic center of a CDA encoded in the P. chlamydosporia genome has been recently confirmed
experimentally [12].
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Large-Mid (70–100 kDa) Mw chitosans are soluble in weak acid solutions (e.g., hydrochloric acid, 
citric acid, acetic acid). Only chitosan oligosaccharides (<5000 Da) are water-soluble. Protonation of 
chitosan amino groups generates positive charges. Both positive charge and amenability to 
structural modifications confer chitosan numerous biological properties. Wide varieties of 
industries use chitosan for different applications. Chitosan has potential for drug-delivery [3,13,14] 
or as a source of biomaterials to generate nanofibers or nanoparticles [15–17]. This review describes 
the mode of action of chitosan in fungi and plants. Figure 2 shows the main features summarized in 
this paper. Our main objectives are: (1) Analyze antimicrobial activity of chitosan; (2) Describe cell 
and gene targets for chitosan in fungi; (3) Illustrate agrobiotechnological applications of chitosan; 
(4) Discuss the effect of chitosan on plant growth and immunity. 
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morphology of economically important post-harvest fungal pathogens (e.g., Rhizopus stolonifer and 
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mycoparasitic fungi (such as Alternaria spp., Colletotrichium spp. or Trichoderma spp.) [20,29–31].  
Chitosan has a great potential as antifungal agent to treat diseases caused by human 
pathogenic fungi [32–36]. Sensitive fungi show energy-dependent plasma membrane 
permeabilisation by chitosan [37]. This polymer also displays antibiotic activity against pathogenic 
bacteria [23,38–41]. Just as for fungi, chitosan permeabilises bacterial plasma membranes [36]. 
Recent studies suggest the use of chitosan as antimicrobial for clinical use [42]. This polymer kills 
opportunistic human pathogens such as Fusarium proliferatum and Hamigera avellanea [43]. Chitosan 
also arrests germination and growth of Fusarium oxysporum f.sp. radicis lycopersici and Verticillium 
dahliae [29]. These fungi are phylogenetically close to opportunistic human pathogens. This polymer 
also restricts growth of other fungal human pathogens such as Aspergillus fumigatus and Rhizopus 
stolonifer. Chitosan inhibits biofilm formation in A. fumigatus [44]. Limitation of nutrients (carbon; C 
and nitrogen; N) enhances chitosan antifungal activity to human pathogens [43]. Deprivation of 
nutrients modifies cell wall architecture which affects fungal growth [43,45–47]. To this respect, low 
branching (glucan content) of fungal cell wall increases sensitivity to chitosan (Figure 2) [11]. There 
is a direct link between cell wall and membrane since the synthesis of key cell wall components 
(glucans and chitin) is performed by plasma membrane-associated synthase complexes [48,49]. 
Chitosan inhibits growth of Candida spp. and Cryptococcus spp. pathogenic yeasts [34,36,42,50–52]. 
As for filamentous fungi, chitosan inhibits C. albicans growth under the same nutritional status 
(carbon) as in human blood (glycemia). Chitosan significantly reduces C. albicans virulence on 
Galleria mellonella L. under these conditions [36]. G. mellonella is a well-established model host to test 
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2. Chitosan as Antimicrobial Agent
Chitosan is a versatile compound with antimicrobial activity [18–21]. Several studies have
investigated the mode of action of chitosan [22–24]. In this review, we present an overview on
the state-of-the-art of chitosan as a natural fungicide. Chitosan affects germination and hyphal
morphology of economically important post-harvest fungal pathogens (e.g., Rhizopus stolonifer and
Botrytis cinerea) [25–28]. This polymer also inhibits the growth of many other plant pathogenic and
mycoparasitic fungi (such as Alternaria spp., Colletotrichium spp. or Trichoderma spp.) [20,29–31].
Chitosan has a great potential as antifungal agent to treat diseases caused by human pathogenic
fungi [32–36]. Sensitive fungi show energy-dependent plasma membrane permeabilisation by
chitosan [37]. This polymer also displays antibiotic activity against pathogenic bacteria [23,38–41].
Just as for fungi, chitosan permeabilises bacterial plasma membranes [36]. Recent studies suggest
the use of chitosan as antimicrobial for clinical use [42]. This polymer kills opportunistic human
pathogens such as Fusarium proliferatum and Hamigera avellanea [43]. Chitosan also arrests germination
and growth of Fusarium oxysporum f.sp. radicis lycopersici and Verticillium dahliae [29]. These fungi
are phylogenetically close to opportunistic human pathogens. This polymer also restricts growth
of other fungal human pathogens such as Aspergillus fumigatus and Rhizopus stolonifer. Chitosan
inhibits biofilm formation in A. fumigatus [44]. Limitation of nutrients (carbon; C and nitrogen; N)
enhances chitosan antifungal activity to human pathogens [43]. Deprivation of nutrients modifies
cell wall architecture which affects fungal growth [43,45–47]. To this respect, low branching (glucan
content) of fungal cell wall increases sensitivity to chitosan (Figure 2) [11]. There is a direct link
between cell wall and membrane since the synthesis of key cell wall components (glucans and chitin)
is performed by plasma membrane-associated synthase complexes [48,49]. Chitosan inhibits growth
of Candida spp. and Cryptococcus spp. pathogenic yeasts [34,36,42,50–52]. As for filamentous fungi,
chitosan inhibits C. albicans growth under the same nutritional status (carbon) as in human blood
(glycemia). Chitosan significantly reduces C. albicans virulence on Galleria mellonella L. under these
conditions [36]. G. mellonella is a well-established model host to test the effect of antimicrobials
on virulence of fungal and bacterial pathogens [53–55]. This polymer is harmless to mammalian
(human and monkey) cells at concentrations fungicidal to human fungal pathogens [43]. This makes it
suitable for clinical application. Nanotechnology allows new chitosan formulations (e.g., nanofibres,
nanocomposites, or nanocapsules) with potential for drug delivery, in medical mycology and
biotechnology [24,56–61]. These findings open-up new possibilities to develop chitosan as a natural
antifungal compound for practical use.
3. Chitosan Alters Gene Expression in Fungi
Several studies have investigated the role of plasma membrane in the sensitivity of fungi to
chitosan [37,62]. The membranes of chitosan-sensitive fungi (e.g., Neurospora crassa) are highly-fluid
(rich in polyunsaturated free fatty acid (FFA) such as linolenic acid). On the contrary, chitosan-resistant
fungi (P. chlamydosporia) have low-fluidity membranes (enriched on saturated FFA such as palmitic or
stearic acid [62]). Recently, our group found that chitosan permeabilises N. crassa plasma membrane
using flow cytometry. This triggers intracellular production of reactive oxygen species (ROS) and cell
death [43]. RNAseq data and gene ontology (GO) analysis reveals oxidoreductase activity, plasma
membrane and transport as main categories induced by chitosan [36]. Chitosan also enriches oxidative
metabolism, respiration and transport GO functions in the model yeast Saccharomyces cerevisiae [63].
S. cerevisiae plasma membrane, response to stress and cell wall integrity genes are induced by
chitosan [64]. Testing deletion strain mutants confirms Lipase Class III, Monosaccharide transporter
and Glutathione transferase encoding genes (NCU03639; NCU04537; NCU10521, respectively) as main
chitosan targets in N. crassa [36]. They might play a role in membrane repair, assimilation of catabolites
and buffering ROS surplus derived from chitosan damage. Antifungal proteins, such as PAF from
Penicillium chrysogenum, have a mode of action similar to chitosan since they also permeabilise plasma
membranes and induce ROS production [65,66]. Synthesis of oxidative by-products of metabolism
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reflects (in peroxisomes and mitochondria) the energetic status of the cell. This would explain why
plasma membrane permeabilisation by chitosan is an energy dependent process [37]. A chemical
or physiological block of the electron transport chain abolishes the antifungal activity of chitosan in
N. crassa [37]. Peroxisome and mainly mitochondria, the main organelles involved in ROS generation,
support the relevance of ROS metabolism in the response of N. crassa to chitosan. The early response of
N. crassa to chitosan involves partial membrane permeabilisation and the onset of ROS production [43].
We hypothesize that chitosan causes an intracellular ROS burst which starts oxidizing FFA from cell
membranes. Increased membrane oxidation finally leads to full plasma membrane permeabilisation
and is perhaps responsible for the antifungal effect of chitosan. Induction of ROS and growth inhibition
also happen under glucose starvation in Candida glabrata [67,68]. This again links nutrient content, ROS
and antifungal action and may explain results described above with chitosan. Future studies should
investigate the generation of oxylipins, metabolites derived from lipid peroxidation, [69] by chitosan
and its relationship with the cellular nutritional status. Recent works describe the involvement of
Ca2+ on plasma membrane remodeling during cell fusion in N. crassa [70,71] and S. cerevisiae [72].
This would explain why Ca2+ increases tolerance to chitosan in N. crassa [36]. On the contrary, N. crassa
syt1 deletion strains involved in plasma membrane homeostasis mediated by Ca2+ [73,74] are more
sensitive to chitosan than the wild-type strain [36]. Figure 3 shows a model we propose on the mode
of action of chitosan on sensitive fungi. The link of ROS, membrane homeostasis, Ca2+ and chitosan is
therefore an attractive subject for future studies [75–77].
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Figure 3. Proposed mode of action of chitosan as a gene modulator on sensitive fungi. A lipase
modifies the plasma embrane increasing its permeability and Ca2+ would mediate this in association
with a calcium regulator membrane fusion protein with a FIG1 domain. Moreover, a onosaccharide
transporter could be involved in the assimilation or detoxification of monomers of N-acetyl glucosamine.
Besides, a glutathione transferase and two dioxygenases may be associated with the response of the
fungus to oxidative stress caused by chitosan increasing reactive oxygen species (ROS) and ATP
production. Finally, the mechanisms of protein synthesis (peroxisome-anchored protein) and resistance
to chemicals (RTA1 domain) have also modifications in their gene expression when exposed to chitosan
(modified from [36]).
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4. Chitosan Acts as Gene Modulator in Tolerant Fungi
Chitosan can be combined with tolerant fungi such as biocontrol fungi (BCF) [29,57,78,79].
BCF can degrade chitosan using it as a nutrient source [29,80]. Nematophagous fungi such as
P. chlamydosporia can withstand high doses of chitosan. The genome of P. chlamydosporia [81]
reveals an expansion of hydrolases. This may reflect the multitrophic (saprotrophic, endophytic,
nematophagous) behavior of the fungus. P. chlamydosporia encodes enzymes to generate and degrade
chitosan such as chitin deacetylases or chitosanases [81]. Recent studies show that chitosan induces
these genes in P. chlamydosporia (mainly cda1, csn1 and csn6) during nematode egg infection [12].
Other studies demonstrate that chitosan also induces P. chlamydosporia proteases [79]. Proteomics
reveals that chitosan alone induces expression of vcp1 serine protease also involved in nematode egg
infection by P. chlamydosporia [82]. Chitosan also induces accumulation of vcp1 and scp1 (a serine
carboxypeptidase) proteases in appressoria of P. chlamydosporia infecting root-knot nematode eggs,
enhancing virulence [79]. Chitosan also increases sporulation of BCF (P. chlamydosporia and Beauveria
bassiana; [29]). Other studies reveal that chitosan enhances growth and sporulation in mycoparasitic
biocontrol fungi Trichoderma spp. (such as T. koningiopsis) [31]. However, other Trichoderma spp. are
hypersensitive to chitosan such as T. harzianun or T. neocrassum [29,31]. Tolerance of fungi to chitosan
depends on the FFA composition as we have explained above. T. knoningiopsis, resistant to chitosan
shows plasma membrane enriched in saturated FFA. Contrarily, other Trichoderma spp. highly sensitive
to chitosan display a large content of poly-unsaturated FFAs [31]. The use of chitosan in combination
with BCF opens new environmentally friendly possibilities to manage pest and diseases caused by
insects, nematodes or fungi.
5. Agrobiotechnological Applications of Chitosan
5.1. Chitosan in Plant Protection
Abuse of pesticides and fertilizers generates environmental pollution, eutrophication and loss
of biodiversity [83–85]. Chitosan is widely used in agriculture on pre- and postharvest treatments
of crops to control microbial infections [56,86,87]. Chitosan can solve these problems minimizing
pollution. For example, nanoparticles of chitosan and porous silica can encapsulate pesticides and
fertilizers and reduce their environmental impact [88]. Application of chitosan to plants protects them
against infections caused by important plant pathogenic fungi such as B. cinerea or F. oxysporum
f.sp. radicis-lycopersici [89–91]. Chitosan promotes parasitism of root-knot nematode eggs by
P. chlamydosporia [79]. In combination with Hirsutella, chitosan can control cyst nematodes in
soybean [92]. In recent studies, chitosan enhances pathogenicity of P. chlamydosporia to root-knot
nematode (RKN) eggs in greenhouse and semi-field experiments [93]. This opens up new strategies
for sustainable management of plant-parasitic nematodes in economically important crops such as
tomato, barley or soybean.
5.2. Chitosan in Crop Growth and Defenses
This polymer also stimulates seed germination and growth of seedlings of ornamental
plants [94,95]. Chitosan is also an elicitor of plant defenses in economically important crops [96,97].
Effects of chitosan on plant development and immunity are revised below.
6. Chitosan Effect on Plant Development
Most chitosan treatments to plants have been performed on leaves. High doses of chitosan
in the rhizosphere of Arabidopsis, tomato or barley significantly arrest root development [98].
Chitosan alters root cell morphology and pattern of division. This abolishes polarity of root apex
growth, stops elongation and modifies root architecture. Arabidopsis thaliana is an adequate tool to
analyze the mechanisms of root growth inhibition by chitosan. Chitosan causes accumulation of auxin
(mainly indole acetic acid; IAA) in Arabidopsis roots. This accumulation is mediated by induction of
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Tryptophan-dependent biosynthesis pathway genes (yuc2, aao1, ami1) and by repression of the main
gene (pin1) involved in IAA translocation [98] (Figure 4). Auxin build-up reduces primary root length
and alters secondary root emergence [99]. Chitosan also affects regulation of gibberellic acid [100].
This polymer also alters patterns of expression of stress-related hormones jasmonic (JA) and salicylic
acid (SA) genes in roots [98]. These transcriptomical and physiological changes can be elicited by
other abiotic stresses [101,102]. Stress caused by application of high chitosan doses causes JA, SA and
ROS accumulation in Arabidopsis roots together with other pleiotropic effects [98]. Cross-talk between
abiotic and biotic stress responses in plants involves ROS and hormone signaling [103]. Therefore,
chitosan irrigation treatments must avoid overstress to plant roots. Chitosan concentrations used in
agricultural practices should restrict growth of pathogens, but favor growth of beneficial fungi (BCF)
and plants.
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Figure 4. Chitosan causes auxin accumulation in roots. This is shown by lack of auxin transport in
the vascular system (no DR5 expression). This auxin accumulation represses wox5, which controls
activity of the quiescent center and in turn root polar growth. As a result, root stops elongating and
root apex thickens. ROS and phenolic accumulation are associated with programmed cell death and
stress-hormone (JA, SA) accumulation.
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7. Plant Immunity: Role of Chitin/Chitosan
Chitin is a key structural component of fungal cell walls. Plant chitinases and glucanases
release chitin and β-glucan oligomers from cell walls of fungal pathogens. These oligomers (MAMPs,
microbe-associated molecular patterns) are recognised by plant membrane PRRs (pattern recognition
receptors) triggering a PTI (pattern-triggered immunity [104]) response. Some fungal pathogens can
modify their cell walls during plant tissue colonisation, turning chitin into chitosan [8,105]. This may
protect hyphae of fungal pathogens from plant chitinases. Very low concentrations (picomolar; pM)
of chitin oligomers can still trigger PTI [106]. Chitin oligomers with large degrees of acetylation and
polymerisation induce main PTI responses (ROS production and alkalinisation) [107–109]. Chitosan
induces callose deposition in plants [110]. Plant immunity also involves overexpression of PR
(Pathogenesis-Related) proteins in response to fungi and other pathogens. PR-4 family includes
class-I and -II chitinases, responsible for chitin degradation [111,112]. Chitosan induces expression
of PR proteins (NPR1) in roots [98] and leaves (PR1 and PR5) [113]. Plant chitinases show less
affinity for chitosan than chitin. Therefore, chitosan is a less efficient MAMP than chitin [8,108].
Chitosan is also a component of the cell wall in germ tube and appressoria in the fungal pathogen
Magnaporthe oryzae [114]. M. oryzae expresses CDAs during appressorium development. Deletion of
these genes compromises conidia germination, adhesion and appressoria differentiation. Application
of exogenous chitosan restores normal development [114]. M. oryzae chitosan on the surface of the leaf
gives stimuli to promote adhesion, appressorium development and plant infection. Therefore, chitosan
could promote evasion of plant immunity and fitness/virulence of fungal pathogens, including
biocontrol agents like P. chlamydosporia. Plant pathogenic fungi also induce other structural changes in
their cell walls to avoid plant defenses such as accumulation of α-1,3-glucan. Masking chitin in fungal
cell walls with α-1,3-glucan also provides protection from plant chitinases. This delays PTI activation
triggered by MAMP (chitin oligomers) recognition [8].
Fungal pathogens also avoid plant immunity shielding cell wall chitin with effectors. These mostly
secreted proteins facilitate pathogen entry into the host and modulate plant immune perception (PTI)
altering host physiology for pathogen’s benefit [115]. LysM effectors bind chitin and chitin oligomers
limiting PTI responses [116]. In this way, they protect fungal pathogens from plant chitinases [8].
They also prevent recognition of chitin oligomers (MAMPs) by plant PRR. Chitin elicitor binding
proteins (CEBiP/CERK) are essential in chitin perception by plants. However, chitosan does not have
specific receptors in plants [117]. This would be an additional reason why chitosan does not efficiently
activate PTI responses. LysM effectors could protect fungal plant pathogens avoiding perception by
mycoparasitic fungi [118]. Likewise, LysM domains can recognise peptidoglycan and could agglutinate
bacterial competitors of plant pathogenic fungi. Just like pathogenic fungi, mutualistic endophytes
(including mycorrhizae) also secrete LysM effectors to suppress plant immunity. These fungi can
manipulate plant hormone signaling associated with plant defenses [115,119]. Chitin derivatives (Nod
and Myc factors) act as symbiotic signaling compounds for rhizobia and mycorrhiza [120,121]. LysM
proteins protect entomopathogenic fungi from insect immune system [122]. B. bassiana activates Blys2
and Blys5 (containing five and two LysM domains, respectively) expression during insect infection.
Blys5 besides chitin can also bind chitosan and cellulose. Both LysM proteins are essential for full
fungal virulence and could protect hyphae from host chitinases.
8. Concluding Remarks
Chitosan is a versatile compound with a wide range of applications. In the clinical field, chitosan
can inhibit filamentous fungi (e.g., Aspergillus fumigatus) and yeast (e.g., Candida albicans) human
pathogens. Application of chitosan under low nutrient (C and N) status favors the antifungal mode of
action of this polymer on human pathogenic fungi. Chitosan also reduces development of the model
fungus N. crassa. Chitosan drastically reduces N. crassa spore germination and growth development.
N. crassa spores exposed to chitosan induce expression of a lipase Class III, a monosaccharide
transporter and a glutathione transferase encoding genes. These are the main chitosan targets in
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this filamentous fungus. A membrane protein ARL1 is the main chitosan target in the model yeast S.
cerevisiae [63]. These proteins could be chitosan targets in fungi and their study could help to develop
chitosan as a drug. On the other hand, chitosan is compatible with several BCF (P. chlamydosporia,
B. bassiana or Trichoderma spp.). A high amount of saturated FFA in the plasma membrane together
with a high glucan/chitin ratio in the cell wall make fungi resistant to chitosan (Figure 2). Chitosan
is also compatible with biocontrol fungi applied in planta. However, application of chitosan on plant
should be highly regulated. High doses of chitosan could block plant (tomato and barley) growth
and development affecting root meristem architecture and organization. In Arabidopsis, the main
transcription factor (WOX5) that regulates cell division in the root quiescent center is repressed by
chitosan [98]. Besides, chitosan also alters hormone homeostasis. Chitosan stimulates auxin (IAA)
accumulation in roots avoiding its translocation. Besides auxin, JA and SA accumulation in roots
would explain changes of cell organisation in Arabidopsis roots exposed to chitosan. Chitosan and
chitin also play a key role controlling plant immunity. Mainly chitin but also chitosan act as MAMPs
triggering a PTI immune response in plants. Chitosan could play a crucial role for fungal endophytes
and pathogens colonizing plants generating a fight between plant immunity and fungal virulence.
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